Found: 70
Select item for more details and to access through your institution.
Divergent downstream biosynthetic pathways are supported by L-cysteine synthases of Mycobacterium tuberculosis.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.91970
- By:
- Publication type:
- Article
Inhibition of protein kinase R protects against palmitic acid–induced inflammation, oxidative stress, and apoptosis through the JNK/NF‐kB/NLRP3 pathway in cultured H9C2 cardiomyocytes.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 3, p. 3651, doi. 10.1002/jcb.27643
- By:
- Publication type:
- Article
N‐Substituted piperazine‐coupled imidazo[2,1‐b]thiazoles as inhibitors of Mycobacterium tuberculosis: Synthesis, evaluation, and docking studies.
- Published in:
- Drug Development Research, 2024, v. 85, n. 1, p. 1, doi. 10.1002/ddr.22153
- By:
- Publication type:
- Article
A Novel, Potent, Small Molecule AKT Inhibitor Exhibits Efficacy against Lung Cancer Cells In Vitro.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 913, doi. 10.4143/crt.2014.057
- By:
- Publication type:
- Article
Structural Models for the Design of PKMzeta Inhibitors with Neurobiological Indications.
- Published in:
- Molecular Informatics, 2015, v. 34, n. 10, p. 665, doi. 10.1002/minf.201500003
- By:
- Publication type:
- Article
Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
- Published in:
- Molecular Informatics, 2015, v. 34, n. 2/3, p. 147, doi. 10.1002/minf.201400120
- By:
- Publication type:
- Article
Discovery of Novel Mycobacterial DNA Gyrase B Inhibitors: In Silico and In Vitro Biological Evaluation.
- Published in:
- Molecular Informatics, 2014, v. 33, n. 9, p. 597, doi. 10.1002/minf.201400058
- By:
- Publication type:
- Article
Multiple e-Pharmacophore Modeling Combined with High-Throughput Virtual Screening and Docking to Identify Potential Inhibitors of β-Secretase(BACE1).
- Published in:
- Molecular Informatics, 2013, v. 32, n. 4, p. 385, doi. 10.1002/minf.201200169
- By:
- Publication type:
- Article
Design, Synthesis, and in vitro antitubercular activity of 1,2,3‐triazolyl‐dihydroquinoline derivatives.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 1, p. 1315, doi. 10.1111/cbdd.13196
- By:
- Publication type:
- Article
Inhibition of tyrosinase by 4 H-chromene analogs: Synthesis, kinetic studies, and computational analysis.
- Published in:
- Chemical Biology & Drug Design, 2017, v. 90, n. 5, p. 804, doi. 10.1111/cbdd.13001
- By:
- Publication type:
- Article
Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2- b]pyridine-1,3,4-oxadiazole derivatives.
- Published in:
- Chemical Biology & Drug Design, 2017, v. 90, n. 4, p. 496, doi. 10.1111/cbdd.12969
- By:
- Publication type:
- Article
Design and Development of Mycobacterium tuberculosis Lysine ɛ-Aminotransferase Inhibitors for Latent Tuberculosis Infection.
- Published in:
- Chemical Biology & Drug Design, 2016, v. 87, n. 2, p. 265, doi. 10.1111/cbdd.12655
- By:
- Publication type:
- Article
Targeting NAMPT for Therapeutic Intervention in Cancer.
- Published in:
- Chemical Biology & Drug Design, 2015, v. 86, n. 4, p. 881, doi. 10.1111/cbdd.12562
- By:
- Publication type:
- Article
Design and Biological Evaluation of Furan/Pyrrole/Thiophene-2-carboxamide Derivatives as Efficient DNA GyraseB Inhibitors of Staphylococcus aureus.
- Published in:
- Chemical Biology & Drug Design, 2015, v. 86, n. 4, p. 918, doi. 10.1111/cbdd.12529
- By:
- Publication type:
- Article
Discovery and Structure Optimization of a Series of Isatin Derivatives as Mycobacterium tuberculosis Chorismate Mutase Inhibitors.
- Published in:
- Chemical Biology & Drug Design, 2014, v. 83, n. 4, p. 498, doi. 10.1111/cbdd.12265
- By:
- Publication type:
- Article
Discovery of Novel 1,2,4-Triazol-5-Ones as Tumor Necrosis Factor-Alpha Inhibitors for the Treatment of Neuropathic Pain.
- Published in:
- Chemical Biology & Drug Design, 2012, v. 80, n. 6, p. 961, doi. 10.1111/cbdd.12049
- By:
- Publication type:
- Article
Synthesis and Antimycobacterial Evaluation of Novel Phthalazin-4-ylacetamides Against log- and Starved Phase Cultures.
- Published in:
- Chemical Biology & Drug Design, 2010, v. 75, n. 4, p. 381, doi. 10.1111/j.1747-0285.2010.00947.x
- By:
- Publication type:
- Article
Indole-2-carboxamides as New Anti-Mycobacterial Agents: Design, Synthesis, Biological Evaluation and Molecular Modeling Against mmpL3.
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2024, v. 20, p. 2
- By:
- Publication type:
- Article
Synthesis of 1,2,3-triazole incorporated monocarbonyl curcumin analogues as potent antitubercular, antifungal and antioxidant agents.
- Published in:
- Chemistry & Biology Interface, 2019, v. 9, n. 1, p. 59
- By:
- Publication type:
- Article
Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 10, p. 1, doi. 10.1371/journal.ppat.1005235
- By:
- Publication type:
- Article
Heteroaryl-substuted semicarbazones: Synthesis and anticonvulsant activity of N-(3-methylpyridin-2-yl)-substituted semicarbazones.
- Published in:
- Journal of Heterocyclic Chemistry, 2006, v. 43, n. 5, p. 1287, doi. 10.1002/jhet.5570430522
- By:
- Publication type:
- Article
Erratum: First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100440
- By:
- Publication type:
- Article
3‐Aryl‐substituted imidazo[1,2‐a]pyridines as antituberculosis agents.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 10, p. 1, doi. 10.1002/ardp.202000419
- By:
- Publication type:
- Article
Synthesis and antimicrobial evaluation of new nitric oxide‐donating fluoroquinolone/oxime hybrids.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 1, p. 1, doi. 10.1002/ardp.202000180
- By:
- Publication type:
- Article
Synthesis of novel 4,5‐dihydropyrrolo[1,2‐a]quinoxalines, pyrrolo[1,2‐a]quinoxalin]‐2‐ones and their antituberculosis and anticancer activity.
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 12, p. 1, doi. 10.1002/ardp.202000192
- By:
- Publication type:
- Article
Unfortunately, in the article Synthesis of novel 4,5‐dihydropyrrolo[1,2‐a]quinoxalines, pyrrolo[1,2‐a]quinoxalin]‐2‐ones and their antituberculosis and anticancer activity.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Pyrazole–coumarin and pyrazole–quinoline chalcones as potential antitubercular agents.
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 8, p. 1, doi. 10.1002/ardp.202000077
- By:
- Publication type:
- Article
Targeting HIV‐TB coinfection by developing novel piperidin‐4‐substituted imines: Design, synthesis, in vitro and in silico studies.
- Published in:
- Archiv der Pharmazie, 2019, v. 352, n. 6, p. 1, doi. 10.1002/ardp.201800358
- By:
- Publication type:
- Article
Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads.
- Published in:
- Journal of Computer-Aided Molecular Design, 2019, v. 33, n. 3, p. 357, doi. 10.1007/s10822-019-00184-1
- By:
- Publication type:
- Article
Advancing host-directed therapy for tuberculosis/MDR-TB: Development of novel AKT inhibitors as an adjunctive treatment for tuberculosis.
- Published in:
- International Journal of Mycobacteriology, 2021, v. 10, p. 70, doi. 10.4103/2212-5531.307123
- By:
- Publication type:
- Article
Identification and Development of Novel Indazole Derivatives as Potent Bacterial Peptidoglycan Synthesis Inhibitors.
- Published in:
- International Journal of Mycobacteriology, 2018, v. 7, n. 1, p. 76, doi. 10.4103/ijmy.ijmy_201_17
- By:
- Publication type:
- Article
Design and development of novel inhibitors for the treatment of latent tuberculosis.
- Published in:
- International Journal of Mycobacteriology, 2016, v. 5, p. S121, doi. 10.1016/j.ijmyco.2016.09.006
- By:
- Publication type:
- Article
Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors.
- Published in:
- International Journal of Mycobacteriology, 2015, v. 4, n. 2, p. 104, doi. 10.1016/j.ijmyco.2015.02.002
- By:
- Publication type:
- Article
Optimization and validation of Mycobacterium marinum-induced adult zebrafish model for evaluation of oral anti-tuberculosis drugs.
- Published in:
- International Journal of Mycobacteriology, 2014, v. 3, n. 4, p. 259, doi. 10.1016/j.ijmyco.2014.10.001
- By:
- Publication type:
- Article
Investigating structure–activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3,5-dione [CD59].
- Published in:
- International Journal of Mycobacteriology, 2014, v. 3, n. 2, p. 117, doi. 10.1016/j.ijmyco.2014.02.006
- By:
- Publication type:
- Article
5-Methyl-4-thiazolidinones: Synthesis and evaluation as antitubercular agents.
- Published in:
- Journal of Research in Pharmacy, 2020, v. 24, n. 1, p. 30, doi. 10.35333/jrp.2020.110
- By:
- Publication type:
- Article
Design and synthesis of novel quinazolinyl-bisspirooxindoles as potent anti-tubercular agents: an ultrasound-promoted methodology.
- Published in:
- Molecular Diversity, 2023, v. 27, n. 3, p. 1427, doi. 10.1007/s11030-022-10500-x
- By:
- Publication type:
- Article
Aryl-n-hexanamide linked enaminones of usnic acid as promising antimicrobial agents.
- Published in:
- Molecular Diversity, 2023, v. 27, n. 2, p. 811, doi. 10.1007/s11030-022-10456-y
- By:
- Publication type:
- Article
Indole-fused spirochromenes as potential anti-tubercular agents: design, synthesis and in vitro evaluation.
- Published in:
- Molecular Diversity, 2021, v. 25, n. 4, p. 2137, doi. 10.1007/s11030-020-10108-z
- By:
- Publication type:
- Article
Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation.
- Published in:
- Molecular Diversity, 2017, v. 21, n. 4, p. 999, doi. 10.1007/s11030-017-9779-y
- By:
- Publication type:
- Article
Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers.
- Published in:
- Molecular Diversity, 2016, v. 20, n. 2, p. 521, doi. 10.1007/s11030-015-9645-8
- By:
- Publication type:
- Article
Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 59, n. 6, p. 1194, doi. 10.1093/jac/dkm085
- By:
- Publication type:
- Article
Novel Thiazolidinone-Azole Hybrids: Design, Synthesis and Antimycobacterial Activity Studies.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2016, v. 15, n. 4, p. 783
- By:
- Publication type:
- Article
Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 3779, doi. 10.2147/DDDT.S83047
- By:
- Publication type:
- Article
Polymer-gold nanoparticle composite films for topical application: Evaluation of physical properties and antibacterial activity.
- Published in:
- Polymer Composites, 2017, v. 38, n. 12, p. 2829, doi. 10.1002/pc.23885
- By:
- Publication type:
- Article
Newer N-Phthaloyl GABA Derivatives with Antiallodynic and Antihyperalgesic Activities in Both Sciatic Nerve and Spinal Nerve Ligation Models of Neuropathic Pain.
- Published in:
- Pharmacology, 2007, v. 81, n. 1, p. 21, doi. 10.1159/000107711
- By:
- Publication type:
- Article
Targeting multiple response regulators of Mycobacterium tuberculosis augments the host immune response to infection.
- Published in:
- Scientific Reports, 2016, p. 25851, doi. 10.1038/srep25851
- By:
- Publication type:
- Article
Structure-Guided Discovery of Antitubercular Agents That Target the Gyrase ATPase Domain.
- Published in:
- ChemMedChem, 2016, v. 11, n. 5, p. 539, doi. 10.1002/cmdc.201500556
- By:
- Publication type:
- Article
Structure-Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors.
- Published in:
- ChemMedChem, 2014, v. 9, n. 11, p. 2538, doi. 10.1002/cmdc.201402171
- By:
- Publication type:
- Article